Pro-moieties of antimicrobial peptide prodrugs (Q35543287)

1 July 2019

2 references

6 August 2019

20 November 2019

Pro-moieties of antimicrobial peptide prodrugs (English)

1 reference

1 July 2019

pharmaceutical preparation

main subject

1 reference

6 August 2019

1 reference

20 November 2019

2

1 reference

1 July 2019

author name string

Eanna Forde

series ordinal

1

1 reference

1 July 2019

language of work or name

English

0 references

publication date

13 January 2015

3 references

1 July 2019

6 August 2019

20 November 2019

3 references

1 July 2019

6 August 2019

20 November 2019

20

1 reference

1 July 2019

issue

1

1 reference

1 July 2019

page(s)

1210-1227

1 reference

1 July 2019

Creative Commons Attribution

copyright license

2 references

6 August 2019

20 November 2019

0 references

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Cationic peptides: effectors in innate immunity and novel antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Antimicrobial peptides of multicellular organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Antimicrobial peptides from animals: focus on invertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Magainins and the disruption of membrane-linked free-energy transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Boosting antimicrobial peptides by hydrophobic oligopeptide end tags

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Targeted antimicrobial peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

The co-evolution of host cationic antimicrobial peptides and microbial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Can innate immunity be enhanced to treat microbial infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

A comprehensive summary of LL-37, the factotum human cathelicidin peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Emerging themes and therapeutic prospects for anti-infective peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Beyond conventional antibiotics for the future treatment of methicillin-resistantStaphylococcus aureusinfections: two novel alternatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Antimicrobial peptides: an overview of a promising class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Prodrugs: design and clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Sensitization of gram-negative bacteria by targeting the membrane potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Pharmacology of polymyxins: new insights into an 'old' class of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Inhaled antibiotics for the treatment of chronic bronchopulmonary Pseudomonas aeruginosa infection in cystic fibrosis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Enhancement of the cancer targeting specificity of buforin IIb by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linker.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Polymer conjugates as anticancer nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Polyacetal−Doxorubicin Conjugates Designed for pH-Dependent Degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Action mechanism of tachyplesin I and effects of PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Action mechanism of PEGylated magainin 2 analogue peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Effects of PEGylation on membrane and lipopolysaccharide interactions of host defense peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Controlled systemic release of therapeutic peptides from PEGylated prodrugs by serum proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Design of a peptibody consisting of the antimicrobial peptide dhvar5 and a llama variable heavy-chain antibody fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Design and activity of a 'dual-targeted' antimicrobial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Synthesis of mutual azo prodrugs of anti-inflammatory agents and peptides facilitated by α-aminoisobutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/MOLECULES20011210

Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers

21 January 2018

1 reference

12 December 2020

In vitro targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two gamma-linked glutamate residues at the COOH terminus.

1 reference

12 December 2020

Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide

1 reference

12 December 2020

Modification of antimicrobial peptide with low molar mass poly(ethylene glycol)

1 reference

12 December 2020

In vivo targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two γ-linked glutamate residues at the COOH terminus

1 reference

12 December 2020

Designing antimicrobial peptides: form follows function.

1 reference

12 December 2020

10.3390/MOLECULES20011210

Identifiers

DOI

1 reference

1 July 2019

PMC publication ID

6272668

1 reference

1 July 2019

PubMed publication ID

25591121

1 reference

1 July 2019